Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Artigo em Francês | MEDLINE | ID: mdl-7005307

RESUMO

Continuous long-term treatments with progestogens are able to bring about an hyperinsulinic reaction, which up till now has been considered to be due to a peripheral anti-insulin effect. Isolating the levels of immuno-reactive plasma insulin and of human C-peptide at the same time when loads of glucose and of tolbutamide are given after one another would seem to demonstrate that there is a primitive beta-islet of Langerhans origin for this hyperinsulinaemia. These results show that it is safe to prescribe etynodiol diacetate to "normal" patients as well as to "diabetic" patients.


Assuntos
Diacetato de Etinodiol/uso terapêutico , Glucose/metabolismo , Insulina/sangue , Adulto , Peptídeo C/sangue , Diacetato de Etinodiol/efeitos adversos , Feminino , Teste de Tolerância a Glucose , Humanos , Fatores de Tempo , Tolbutamida , Doenças Uterinas/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...